Outcomes of tracheobronchial stent placement for benign disease

Raymond H. Thornton, Roy L. Gordon, Robert K. Kerlan, Jeanne M. LaBerge, Mark W. Wilson, Kristen A. Wolanske, Michael Gotway, Geoffrey S. Hastings, Jeffrey A. Golden

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Purpose: To retrospectively determine long-term outcomes in patients who have undergone tracheobronchial stent placement for benign diseases. Materials and Methods: Institutional Review Board approval was obtained for this retrospective HIPAA-compliant study, with waiver of informed consent. Forty patients (22 female, 18 male; mean age, 52.0 years) who were treated with metallic airway stents for benign stenosis were identified from an interventional radiology database. Causes of airway stenosis included transplant stricture (n = 13), tracheal tube injury (n -10), inflammation (n = 6), tracheobronchomalacia (n = 4), infection (n = 3), and extrinsic compression (n = 4). Follow-up, which ranged from 6 to 2473 days, was performed by means of chart review for deceased patients and by means of clinical visit or telephone interview for surviving patients. Survival, primary patency, and assisted patency were estimated by using the Kaplan-Meier product limits method. Results: Initial technical success was achieved in all cases. Symptomatic improvement was present in 39 of 40 cases. At review, 15 patients were alive and had clinical improvement, 18 had died of comorbid causes, one had died of uncertain causes, three had undergone subsequent airway surgery, two had undergone airway stent retrieval, and one was lost to follow-up. Survival at 1, 2, 3, 4, 5, and 6 years was 79%, 76%, 51 %, 47%, 38%, and 23%, respectively. Loss of primary patency was most rapid during the 1st year. With repeat intervention, assisted patency was 90% at 6.8 years. Conclusion: Attrition of tracheobronchial stent patency is most rapid during the 1st year, and a high rate of long-term patency can be achieved with secondary interventions. Metallic airway stents are well-tolerated and useful adjuncts for management of select benign tracheobronchial stenoses.

Original languageEnglish (US)
Pages (from-to)273-282
Number of pages10
JournalRadiology
Volume240
Issue number1
DOIs
StatePublished - Jul 2006
Externally publishedYes

Fingerprint

Stents
Pathologic Constriction
Tracheobronchomalacia
Health Insurance Portability and Accountability Act
Interventional Radiology
Survival
Research Ethics Committees
Lost to Follow-Up
Kaplan-Meier Estimate
Informed Consent
Databases
Interviews
Inflammation
Transplants
Wounds and Injuries
Infection

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Thornton, R. H., Gordon, R. L., Kerlan, R. K., LaBerge, J. M., Wilson, M. W., Wolanske, K. A., ... Golden, J. A. (2006). Outcomes of tracheobronchial stent placement for benign disease. Radiology, 240(1), 273-282. https://doi.org/10.1148/radiol.2401042169

Outcomes of tracheobronchial stent placement for benign disease. / Thornton, Raymond H.; Gordon, Roy L.; Kerlan, Robert K.; LaBerge, Jeanne M.; Wilson, Mark W.; Wolanske, Kristen A.; Gotway, Michael; Hastings, Geoffrey S.; Golden, Jeffrey A.

In: Radiology, Vol. 240, No. 1, 07.2006, p. 273-282.

Research output: Contribution to journalArticle

Thornton, RH, Gordon, RL, Kerlan, RK, LaBerge, JM, Wilson, MW, Wolanske, KA, Gotway, M, Hastings, GS & Golden, JA 2006, 'Outcomes of tracheobronchial stent placement for benign disease', Radiology, vol. 240, no. 1, pp. 273-282. https://doi.org/10.1148/radiol.2401042169
Thornton RH, Gordon RL, Kerlan RK, LaBerge JM, Wilson MW, Wolanske KA et al. Outcomes of tracheobronchial stent placement for benign disease. Radiology. 2006 Jul;240(1):273-282. https://doi.org/10.1148/radiol.2401042169
Thornton, Raymond H. ; Gordon, Roy L. ; Kerlan, Robert K. ; LaBerge, Jeanne M. ; Wilson, Mark W. ; Wolanske, Kristen A. ; Gotway, Michael ; Hastings, Geoffrey S. ; Golden, Jeffrey A. / Outcomes of tracheobronchial stent placement for benign disease. In: Radiology. 2006 ; Vol. 240, No. 1. pp. 273-282.
@article{56ae68f2f791426294aa63093458e335,
title = "Outcomes of tracheobronchial stent placement for benign disease",
abstract = "Purpose: To retrospectively determine long-term outcomes in patients who have undergone tracheobronchial stent placement for benign diseases. Materials and Methods: Institutional Review Board approval was obtained for this retrospective HIPAA-compliant study, with waiver of informed consent. Forty patients (22 female, 18 male; mean age, 52.0 years) who were treated with metallic airway stents for benign stenosis were identified from an interventional radiology database. Causes of airway stenosis included transplant stricture (n = 13), tracheal tube injury (n -10), inflammation (n = 6), tracheobronchomalacia (n = 4), infection (n = 3), and extrinsic compression (n = 4). Follow-up, which ranged from 6 to 2473 days, was performed by means of chart review for deceased patients and by means of clinical visit or telephone interview for surviving patients. Survival, primary patency, and assisted patency were estimated by using the Kaplan-Meier product limits method. Results: Initial technical success was achieved in all cases. Symptomatic improvement was present in 39 of 40 cases. At review, 15 patients were alive and had clinical improvement, 18 had died of comorbid causes, one had died of uncertain causes, three had undergone subsequent airway surgery, two had undergone airway stent retrieval, and one was lost to follow-up. Survival at 1, 2, 3, 4, 5, and 6 years was 79{\%}, 76{\%}, 51 {\%}, 47{\%}, 38{\%}, and 23{\%}, respectively. Loss of primary patency was most rapid during the 1st year. With repeat intervention, assisted patency was 90{\%} at 6.8 years. Conclusion: Attrition of tracheobronchial stent patency is most rapid during the 1st year, and a high rate of long-term patency can be achieved with secondary interventions. Metallic airway stents are well-tolerated and useful adjuncts for management of select benign tracheobronchial stenoses.",
author = "Thornton, {Raymond H.} and Gordon, {Roy L.} and Kerlan, {Robert K.} and LaBerge, {Jeanne M.} and Wilson, {Mark W.} and Wolanske, {Kristen A.} and Michael Gotway and Hastings, {Geoffrey S.} and Golden, {Jeffrey A.}",
year = "2006",
month = "7",
doi = "10.1148/radiol.2401042169",
language = "English (US)",
volume = "240",
pages = "273--282",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "1",

}

TY - JOUR

T1 - Outcomes of tracheobronchial stent placement for benign disease

AU - Thornton, Raymond H.

AU - Gordon, Roy L.

AU - Kerlan, Robert K.

AU - LaBerge, Jeanne M.

AU - Wilson, Mark W.

AU - Wolanske, Kristen A.

AU - Gotway, Michael

AU - Hastings, Geoffrey S.

AU - Golden, Jeffrey A.

PY - 2006/7

Y1 - 2006/7

N2 - Purpose: To retrospectively determine long-term outcomes in patients who have undergone tracheobronchial stent placement for benign diseases. Materials and Methods: Institutional Review Board approval was obtained for this retrospective HIPAA-compliant study, with waiver of informed consent. Forty patients (22 female, 18 male; mean age, 52.0 years) who were treated with metallic airway stents for benign stenosis were identified from an interventional radiology database. Causes of airway stenosis included transplant stricture (n = 13), tracheal tube injury (n -10), inflammation (n = 6), tracheobronchomalacia (n = 4), infection (n = 3), and extrinsic compression (n = 4). Follow-up, which ranged from 6 to 2473 days, was performed by means of chart review for deceased patients and by means of clinical visit or telephone interview for surviving patients. Survival, primary patency, and assisted patency were estimated by using the Kaplan-Meier product limits method. Results: Initial technical success was achieved in all cases. Symptomatic improvement was present in 39 of 40 cases. At review, 15 patients were alive and had clinical improvement, 18 had died of comorbid causes, one had died of uncertain causes, three had undergone subsequent airway surgery, two had undergone airway stent retrieval, and one was lost to follow-up. Survival at 1, 2, 3, 4, 5, and 6 years was 79%, 76%, 51 %, 47%, 38%, and 23%, respectively. Loss of primary patency was most rapid during the 1st year. With repeat intervention, assisted patency was 90% at 6.8 years. Conclusion: Attrition of tracheobronchial stent patency is most rapid during the 1st year, and a high rate of long-term patency can be achieved with secondary interventions. Metallic airway stents are well-tolerated and useful adjuncts for management of select benign tracheobronchial stenoses.

AB - Purpose: To retrospectively determine long-term outcomes in patients who have undergone tracheobronchial stent placement for benign diseases. Materials and Methods: Institutional Review Board approval was obtained for this retrospective HIPAA-compliant study, with waiver of informed consent. Forty patients (22 female, 18 male; mean age, 52.0 years) who were treated with metallic airway stents for benign stenosis were identified from an interventional radiology database. Causes of airway stenosis included transplant stricture (n = 13), tracheal tube injury (n -10), inflammation (n = 6), tracheobronchomalacia (n = 4), infection (n = 3), and extrinsic compression (n = 4). Follow-up, which ranged from 6 to 2473 days, was performed by means of chart review for deceased patients and by means of clinical visit or telephone interview for surviving patients. Survival, primary patency, and assisted patency were estimated by using the Kaplan-Meier product limits method. Results: Initial technical success was achieved in all cases. Symptomatic improvement was present in 39 of 40 cases. At review, 15 patients were alive and had clinical improvement, 18 had died of comorbid causes, one had died of uncertain causes, three had undergone subsequent airway surgery, two had undergone airway stent retrieval, and one was lost to follow-up. Survival at 1, 2, 3, 4, 5, and 6 years was 79%, 76%, 51 %, 47%, 38%, and 23%, respectively. Loss of primary patency was most rapid during the 1st year. With repeat intervention, assisted patency was 90% at 6.8 years. Conclusion: Attrition of tracheobronchial stent patency is most rapid during the 1st year, and a high rate of long-term patency can be achieved with secondary interventions. Metallic airway stents are well-tolerated and useful adjuncts for management of select benign tracheobronchial stenoses.

UR - http://www.scopus.com/inward/record.url?scp=33745180844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745180844&partnerID=8YFLogxK

U2 - 10.1148/radiol.2401042169

DO - 10.1148/radiol.2401042169

M3 - Article

C2 - 16793984

AN - SCOPUS:33745180844

VL - 240

SP - 273

EP - 282

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 1

ER -